{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:42:21Z","timestamp":1781664141482,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.diabres.2022.109226","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T17:38:04Z","timestamp":1643823484000},"page":"109226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Fucosylated AGP glycopeptides as biomarkers of HNF1A-Maturity onset diabetes of the young"],"prefix":"10.1016","volume":"185","author":[{"given":"Marko","family":"Tijardovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"\u0160tambuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Juszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toma","family":"Keser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gasperikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mislav","family":"Novokmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erling","family":"Tjora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edita","family":"Pape Medvidovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Stanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Rasmus Nj\u00f8lstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordan","family":"Lauc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine R.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Gornik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.diabres.2022.109226_b0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrendo.2016.50","article-title":"Common and rare forms of diabetes mellitus: towards a continuum of diabetes subtypes","volume":"12","author":"Flannick","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.diabres.2022.109226_b0010","doi-asserted-by":"crossref","unstructured":"Anik A, \u00c7atli G, Abaci A, and B\u00f6ber E. \u201cMaturity-onset diabetes of the young (MODY): An update,\u201d Journal of Pediatric Endocrinology and Metabolism, vol. 28, no. 3\u20134. Walter de Gruyter GmbH, pp. 251\u2013263, Mar. 01, 2015, doi: 10.1515\/jpem-2014-0384.","DOI":"10.1515\/jpem-2014-0384"},{"key":"10.1016\/j.diabres.2022.109226_b0015","first-page":"1047","article-title":"\u201cMaturity-onset diabetes of the young (MODY): Current perspectives on diagnosis and treatment\u201d","volume":"vol. 12","author":"Urakami","year":"2019"},{"issue":"12","key":"10.1016\/j.diabres.2022.109226_b0020","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1007\/s00125-010-1799-4","article-title":"Maturity-onset diabetes of the young (MODY): How many cases are we missing?","volume":"53","author":"Shields","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2022.109226_b0025","unstructured":"Kavvoura FK and Owen KR. \u201cMaturity onset diabetes of the young: clinical characteristics, diagnosis and management.,\u201d Pediatric endocrinology reviews : PER, vol. 10, no. 2. pp. 234\u2013242, Dec. 01, 2012."},{"issue":"9392","key":"10.1016\/j.diabres.2022.109226_b0030","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(03)14571-0","article-title":"Genetic cause of hyperglycaemia and response to treatment in diabetes","volume":"362","author":"Pearson","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.diabres.2022.109226_b0035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/humu.22279","article-title":"Mutations in the Genes Encoding the Transcription Factors Hepatocyte Nuclear Factor 1 Alpha and 4 Alpha in Maturity-Onset Diabetes of the Young and Hyperinsulinemic Hypoglycemia","volume":"34","author":"Colclough","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.diabres.2022.109226_b0040","doi-asserted-by":"crossref","unstructured":"Harries LW. et al., \u201cIsomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes,\u201d Hum. Mol. Genet., vol. 15, no. 14, pp. 2216\u20132224, Jul. 2006, doi: 10.1093\/hmg\/ddl147.","DOI":"10.1093\/hmg\/ddl147"},{"issue":"11","key":"10.1016\/j.diabres.2022.109226_b0045","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ng.2794","article-title":"Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes","volume":"45","author":"Flannick","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2022.109226_b0050","series-title":"Essentials of Glycobiology","author":"Varki","year":"2017"},{"issue":"12","key":"10.1016\/j.diabres.2022.109226_b0055","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1007\/s00125-017-4426-9","article-title":"Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes","volume":"60","author":"Keser","year":"2017","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.diabres.2022.109226_b0060","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.bbagen.2018.08.005","article-title":"Plasma protein N-glycan signatures of type 2 diabetes","volume":"1862","author":"Dotz","year":"2018","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"issue":"3","key":"10.1016\/j.diabres.2022.109226_b0065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2337\/dc19-1507","article-title":"Plasma N-glycans as emerging biomarkers of cardiometabolic risk: A prospective investigation intheepic-potsdamcohortstudy","volume":"43","author":"Wittenbecher","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109226_b0070","doi-asserted-by":"crossref","unstructured":"Pavi\u0107 T. et al., \u201cMaturity onset diabetes of the young due to HNF1A variants in Croatia,\u201d Biochem. Medica, vol. 28, no. 2 Special Issue, 2018, doi: 10.11613\/BM.2018.020703.","DOI":"10.11613\/BM.2018.020703"},{"key":"10.1016\/j.diabres.2022.109226_b0075","doi-asserted-by":"crossref","unstructured":"Rudman N, Gornik O, and Lauc G. \u201cAltered N-glycosylation profiles as potential biomarkers and drug targets in diabetes,\u201d FEBS Letters, vol. 593, no. 13. Wiley Blackwell, pp. 1598\u20131615, Jul. 01, 2019, doi: 10.1002\/1873-3468.13495.","DOI":"10.1002\/1873-3468.13495"},{"key":"10.1016\/j.diabres.2022.109226_b0080","doi-asserted-by":"crossref","unstructured":"Lauc G. et al., \u201cGenomics meets glycomics-the first gwas study of human N-glycome identifies HNF1A as a master regulator of plasma protein fucosylation,\u201d PLoS Genet., vol. 6, no. 12, pp. 1\u201314, 2010, doi: 10.1371\/journal.pgen.1001256.","DOI":"10.1371\/journal.pgen.1001256"},{"issue":"4","key":"10.1016\/j.diabres.2022.109226_b0085","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/db12-0880","article-title":"Mutations in HNF1A result in marked alterations of plasma glycan profile","volume":"62","author":"Thanabalasingham","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2022.109226_b0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2337\/dc18-0422","article-title":"Plasma fucosylated glycans and C-reactive protein as biomarkers of HNF1A-MODY in young adult\u2013onset nonautoimmune diabetes","volume":"42","author":"Juszczak","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2022.109226_b0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10719-015-9626-2","article-title":"Human plasma protein N-glycosylation","volume":"33","author":"Clerc","year":"2016","journal-title":"Glycoconj. J."},{"issue":"2","key":"10.1016\/j.diabres.2022.109226_b0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0005-2795(77)90080-0","article-title":"The carbohydrate units of human plasma \u03b11-Acid glycoprotein","volume":"492","author":"Schmid","year":"1977","journal-title":"BBA - Protein Struct."},{"key":"10.1016\/j.diabres.2022.109226_b0105","first-page":"7","article-title":"Human plasma alpha 1-acid glycoprotein\u2013biochemical properties, the amino acid sequence and the structure of the carbohydrate moiety, variants and polymorphism","volume":"300","author":"Schmid","year":"1989","journal-title":"Prog Clin Biol Res."},{"issue":"8","key":"10.1016\/j.diabres.2022.109226_b0110","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/j.1460-2075.1987.tb02503.x","article-title":"Structure and expression of the genes coding for human alpha 1-acid glycoprotein","volume":"6","author":"Dente","year":"1987","journal-title":"EMBO J."},{"key":"10.1016\/j.diabres.2022.109226_b0115","doi-asserted-by":"crossref","first-page":"100044","DOI":"10.1074\/mcp.RA120.002433","article-title":"High-Throughput and Site-Specific N-Glycosylation Analysis of Human Alpha-1-Acid Glycoprotein Offers a Great Potential for New Biomarker Discovery","volume":"20","author":"Keser","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"issue":"5","key":"10.1016\/j.diabres.2022.109226_b0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"issue":"8","key":"10.1016\/j.diabres.2022.109226_b0125","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1093\/nar\/gkh581","article-title":"Hepatocyte nuclear factor 4\u03b1 enhances the hepatocyte nuclear factor 1\u03b1-mediated activation of transcription","volume":"32","author":"Eeckhoute","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.diabres.2022.109226_b0130","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1002\/cncr.20713","article-title":"alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis","volume":"101","author":"Hashimoto","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.diabres.2022.109226_b0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1012412908983","article-title":"Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function","volume":"18","author":"Poland","year":"2001","journal-title":"Glycoconj. J."},{"issue":"1\u20132","key":"10.1016\/j.diabres.2022.109226_b0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0009-8981(01)00803-8","article-title":"Fucosylation of \u03b11-acid glycoprotein (orosomucoid) compared with traditional biochemical markers of inflammation in recent onset rheumatoid arthritis","volume":"317","author":"Ryd\u00e9n","year":"2002","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.diabres.2022.109226_b0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2217\/dmt.12.82","article-title":"Biomarkers currently used for the diagnosis of maturity-onset diabetes of the young","volume":"3","author":"Mughal","year":"2013","journal-title":"Diabetes Management"},{"issue":"5","key":"10.1016\/j.diabres.2022.109226_b0150","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00125-011-2418-8","article-title":"The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes","volume":"55","author":"Shields","year":"2012","journal-title":"Diabetologia"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:19:40Z","timestamp":1759173580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":30,"alternative-id":["S0168822722000389"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109226","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fucosylated AGP glycopeptides as biomarkers of HNF1A-Maturity onset diabetes of the young","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109226"}}